Purchase Order 36C26121P1033
Award Date 5/20/21
Potential Completion Date 5/28/21
Potential Value $285K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for YESCARTA Drug. The contract has a period of performance from March 22, 2022 through March 28, 2022 and utilizes a firm fixed price pricing structure. Cardinal Health, Inc. will provide YESCARTA, a chimeric antigen receptor T-cell therapy, as the prime contractor.</p>
- Cardinal Health, Inc. was awarded a $285,000 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to deliver YESCARTA (axicabtagene ciloleucel) injections for cancer treatment. As the prime contractor, Cardinal Health will provide the chimeric antigen receptor T-cell immunotherapy drug manufactured by Kite Pharma, Inc. from its manufacturing facility in Dublin, Ohio for administration to veterans through VA medical centers...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA-VHA) awarded a $287,923.29 purchase order contract to Cardinal Health, Inc. for YESCARTA Therapy. As the prime contractor, Cardinal Health Inc. Division - doing business as Cardinal Health, will provide YESCARTA Therapy from August 18, 2022 through February 28, 2023 in Dublin, Ohio under firm fixed pricing terms. YESCARTA is a chimeric antigen receptor (CAR) T-cell immunotherapy...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for EMERGENCY-YESCARTA. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, will provide the products or services defined in the EMERGENCY-YESCARTA solicitation from their place of performance in Dublin, Ohio, between November 30, 2022 and December 2, 2022. The...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $284,904.52 purchase order contract to Cardinal Health, Inc., doing business as Cardinal Health, for YESCART (AXICABTAGENE CILOLEUCEL INJ SUSP). The place of performance is Dublin, OH and the contract period is from November 30, 2021 to December 1, 2021. The pricing structure is firm fixed price. No subcontractors were identified.</p>
- This federal contract for $148,339.41 was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of emergency radiopharmaceuticals to the VA for a one-month period ending October 31, 2023. The contract is a firm fixed price purchase order with no set-aside designation. Cardinal Health 414 has extensive experience providing radiopharmaceuticals, nuclear medicine...
- This federal contract award for $356,852.35 was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The award is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract between the VA and Cardinal Health for the supply of various radiopharmaceuticals used in nuclear medicine, oncology, and diagnostic imaging services. The contract has a period of performance through September 30, 2024 and is structured as a...
- This federal contract award, valued at $97,959.79, was issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, which are specialized medical products used in nuclear medicine, oncology, and diagnostic imaging services. This contract has no set-aside designation, indicating that Cardinal Health 414 is a large,...
- This federal contract award, valued at $84,818.28, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products to support nuclear medicine, oncology, and diagnostic imaging services at VA medical facilities. The contract is a single-award Indefinite Delivery Vehicle (IDV) with a base period from June 15, 2018, to June...
- This is a federal contract award from the Defense agency's Medical Supply Chain, with an award value of $13,190.90 and an ultimate completion date of October 31, 2024. The contract was awarded to Cardinal Health, Inc., a global healthcare services and products company, and does not have a set-aside designation. The contract appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $6,950,000.00, which is focused on providing radiopharmaceutical products to the...